These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
172 related items for PubMed ID: 15699504
21. Comparison of immunoassays for the detection of anti-GAD65 autoantibodies in patients with diabetes mellitus. Pfützner A, Harzer O, Kunt T, Forst T, Abdollahnia N, Löbig M, Krauss H, Engelbach M, Kann P, Beyer J. Clin Lab; 2000; 46(5-6):275-9. PubMed ID: 10853236 [Abstract] [Full Text] [Related]
24. Diagnostic value of carboxypeptidase-H autoantibodies in detecting latent autoimmune diabetes in adults. Zhou ZG, Yang L, Huang G. Hunan Yi Ke Da Xue Xue Bao; 2003 Dec; 28(6):549-52. PubMed ID: 15804058 [Abstract] [Full Text] [Related]
30. [Diagnostic usefulness of glutamic acid decarboxylase antibodies in stiff-man syndrome]. Saiz A, Arias M, Fernández-Barreiro A, Mínguez A, Casamitjana R, Tolosa E, Graus F. Med Clin (Barc); 1998 Mar 21; 110(10):378-81. PubMed ID: 9567281 [Abstract] [Full Text] [Related]
31. T-cell responses to islet antigens improves detection of autoimmune diabetes and identifies patients with more severe beta-cell lesions in phenotypic type 2 diabetes. Goel A, Chiu H, Felton J, Palmer JP, Brooks-Worrell B. Diabetes; 2007 Aug 21; 56(8):2110-5. PubMed ID: 17473222 [Abstract] [Full Text] [Related]
32. Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association. Saiz A, Blanco Y, Sabater L, González F, Bataller L, Casamitjana R, Ramió-Torrentà L, Graus F. Brain; 2008 Oct 21; 131(Pt 10):2553-63. PubMed ID: 18687732 [Abstract] [Full Text] [Related]
34. [Clinical characteristics and main diagnostic points of latent autoimmune diabetes mellitus in adults]. Pan X, Yang W, Xiao J. Zhonghua Nei Ke Za Zhi; 1997 Mar 21; 36(3):159-64. PubMed ID: 10374307 [Abstract] [Full Text] [Related]
35. GAD antibodies in probands and their relatives in a cohort clinically selected for Type 2 diabetes. Castleden HA, Shields B, Bingley PJ, Williams AJ, Sampson M, Walker M, Gibson JM, McCarthy MI, Hitman GA, Levy JC, Hattersley AT, Vaidya B, Pearson ER. Diabet Med; 2006 Aug 21; 23(8):834-8. PubMed ID: 16911619 [Abstract] [Full Text] [Related]
36. Equivalent insulin resistance in latent autoimmune diabetes in adults (LADA) and type 2 diabetic patients. Chiu HK, Tsai EC, Juneja R, Stoever J, Brooks-Worrell B, Goel A, Palmer JP. Diabetes Res Clin Pract; 2007 Aug 21; 77(2):237-44. PubMed ID: 17234296 [Abstract] [Full Text] [Related]
37. Prevalence and clinical characteristics of insulin-treated, anti-GAD-positive, type 2 diabetic subjects in an outpatient clinical department of a Dutch teaching hospital. Römkens TE, Kusters GC, Netea MG, Netten PM. Neth J Med; 2006 Apr 21; 64(4):114-8. PubMed ID: 16609158 [Abstract] [Full Text] [Related]
38. A clinical screening tool identifies autoimmune diabetes in adults. Fourlanos S, Perry C, Stein MS, Stankovich J, Harrison LC, Colman PG. Diabetes Care; 2006 May 21; 29(5):970-5. PubMed ID: 16644622 [Abstract] [Full Text] [Related]
39. [Diagnostic role of SOX13 antibody in latent autoimmune diabetes of adults]. Li LR, Zhou ZG, Huang G, Yang L, Li X, Chen XY, He L. Zhonghua Yi Xue Za Zhi; 2005 Jan 26; 85(4):235-9. PubMed ID: 15854483 [Abstract] [Full Text] [Related]
40. Anti-glutamic acid decarboxylase antibodies in the serum and cerebrospinal fluid of patients with stiff-person syndrome: correlation with clinical severity. Rakocevic G, Raju R, Dalakas MC. Arch Neurol; 2004 Jun 26; 61(6):902-4. PubMed ID: 15210528 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]